Psy Therapeutics

About:

Psy Therapeutics discovers and develops novel medicines to improve the lives of people affected by central nervous system disorders.

Website: https://www.psythx.com/

Top Investors: WPSS.bio, Ayuh Ventures

Description:

Psy Therapeutics is discovering and developing novel medicines to improve the lives of people affected by central nervous system (CNS) disorders. The company focuses on anxiety, depression, and dementia to improve neuropsychiatric care.

Total Funding Amount:

$3.97M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2012-01-01

Founders:

Jerrold Rosenbaum, Maurizio Fava, Roy Perlis

Number of Employees:

11-50

Last Funding Date:

2022-04-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai